ABEONA THERAPEUTICS INC. — Cash Flow Charts
16 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-16.2% -$11M
$-76M
Free Cash Flow↓-20.7% -$14M
$-84M
Investing Cash Flow↑+59.0% +$39M
$105M
Financing Cash Flow↑+4.7% +$1M
$26M
Capex↑+92.1% +$4M
$8M
Stock-Based Comp
$11M
Debt Issued
$20M
D&A↓-21.6% -$701K
$3M
SBC Allocated Expense↑+20.9% +$2M
$11M
SBC Unrecognized Cost
$53K